IBT Stock Overview
International Biotechnology Trust plc specializes in investments in development stage and late stage companies.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
International Biotechnology Trust plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£6.18 |
| 52 Week High | UK£7.04 |
| 52 Week Low | UK£5.48 |
| Beta | 0.21 |
| 1 Month Change | -6.08% |
| 3 Month Change | -2.22% |
| 1 Year Change | -7.49% |
| 3 Year Change | -18.31% |
| 5 Year Change | -1.28% |
| Change since IPO | 550.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| IBT | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | -1.4% | -2.2% | -0.9% |
| 1Y | -7.5% | 6.7% | -1.8% |
Return vs Industry: IBT underperformed the UK Capital Markets industry which returned 6.7% over the past year.
Return vs Market: IBT underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| IBT volatility | |
|---|---|
| IBT Average Weekly Movement | 2.3% |
| Capital Markets Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: IBT has not had significant price volatility in the past 3 months.
Volatility Over Time: IBT's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | n/a | www.internationalbiotrust.com |
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund’s assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
International Biotechnology Trust plc Fundamentals Summary
| IBT fundamental statistics | |
|---|---|
| Market cap | UK£233.59m |
| Earnings (TTM) | UK£6.81m |
| Revenue (TTM) | UK£10.47m |
34.3x
P/E Ratio22.3x
P/S RatioIs IBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IBT income statement (TTM) | |
|---|---|
| Revenue | UK£10.47m |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£10.47m |
| Other Expenses | UK£3.66m |
| Earnings | UK£6.81m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 100.00% |
| Net Profit Margin | 65.08% |
| Debt/Equity Ratio | 12.0% |
How did IBT perform over the long term?
See historical performance and comparison